Sign Out
For Adult Population: Treatment of Erosive Gastroesophageal Reflux Disease: 50 mg once daily for 4 weeks. For patients who do not heal or have persistent symptoms after 4 weeks, an additional 4-week treatment may be considered.
Treatment of Non-Erosive Gastroesophageal Reflux Disease: 50 mg once daily for 4 weeks.
Treatment of Gastric Ulcer: 50 mg once daily for 8 weeks.
Eradication of H. pylori concurrently given with appropriate antibiotic therapy treatment in patients with peptic ulcer and/or chronic atrophic gastritis:
Patients with H. pylori infection should be treated with eradication therapy. Tegoprazan 50 mg, clarithromycin 500 mg, and amoxicillin 1 g are orally administered twice daily for 7 days.
K-CAB can be taken with or without food.
For Pediatric Population: Clinical safety and efficacy of K-CAB in Pediatric and adolescent patients have not been established.
